Antipsychotics Linked to Sudden Cardiac Death

Doctor with RX prescriptionAntipsychotic drugs have proven to be one of the most profitable commodities of Big Pharma. In fact, Zyprexa has made Eli Lilly over $70 billion. It is sold at $12 a pill and is used by many state institutions and state foster care programs, at a steep cost to the tax payer.

However, a recent study has shown that Zyprexa, Risperdal, Haldol, and other antipsychotics dramatically increase the risk of sudden cardiac death (SCD). In fact, the Oregon Sudden Unexplained Death Study conducted by Dr. Audrey Uy-Evanado of Cedars-Sinai Medical Center in Los Angeles found that individuals on these drugs tripled their risk of sudden cardiac death and that there is a direct link between these drugs and this fatal condition.

No one should have to die as the result of treatment with these drugs and families who have had a member do so should seriously consider bringing a legal suit against the drug manufacturer.

In order to be successful against Big Pharma in such a lawsuit concerning, one would need to show that the medication was the cause of death and other factors must be ruled out or shown not to be the cause of death. Medical research now appears to back up such a claim.

Consumers need to be protected and drug manufacturers who allow such dangerous products to be on the market should be punished.